MarkBJuckettMDMHCM

PubMed

• Correction: Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease.
  Jenna L Hansen, Mark B Juckett, Mikayla A Foster, Meredith E Rumble, Keayra E Morris, Peiman Hematti, Erin S Costanzo> ;Journal of Cancer Survivorship. 2023 Aug 23
• TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience.
  Vaishalee P Kenkre, Kristin Bradley, Arissa Milton, Joseph K Burkholder, Kreg Grindle, Jan McMannes, KyungMann Kim, Natalie Callander, Mark Juckett, Walter Longo, Peim...> ;Leukemia & Lymphoma. 2023 Aug 10
• 3 citations
  Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.
  Najla El Jurdi, Alex Hoover, Daniel O'Leary, Qing Cao, Ashish Gupta, Christen Ebens, Joseph E Maakaron, Brian C Betts, Armin Rashidi, Mark B Juckett, Troy Lund, Veroni...> ;Transplantation and Cellular Therapy. 2023 Sep 1
• 1 citations
  Inflammatory cytokines and depression symptoms following hematopoietic cell transplantation.
  Ashley M Nelson, Alexandra A Erdmann, Christopher L Coe, Mark B Juckett, Keayra Morris, Jennifer M Knight, Peiman Hematti, Erin S Costanzo> ;Brain, Behavior, and Immunity. 2023 Aug 1
• 1 citations
  Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers.
  Akshay Sharma, Brent Logan, Noel Estrada-Merly, Leslie E Lehmann, Hemalatha G Rangarajan, Jaime M Preussler, Jesse D Troy, Luke P Akard, Neel S Bhatt, Tony H Truong, W...> ;Transplantation and Cellular Therapy. 2023 Aug 1
• 2 citations
  Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction ...
  Najla El Jurdi, Alex Hoover, Daniel O'Leary, Qing Cao, Ashish Gupta, Christen Ebens, Joseph Maakaron, Brian C Betts, Armin Rashidi, Mark Juckett, Troy Lund, Veronika B...> ;Medrxiv. 2023 Mar 29
• 1 citations
  Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease.
  Jenna L Hansen, Mark B Juckett, Mikayla A Foster, Meredith E Rumble, Keayra E Morris, Peiman Hematti, Erin S Costanzo> ;Journal of Cancer Survivorship. 2023 Jun 1
• 1 citations
  A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodyspl...
  Armin Rashidi, Eric J Huselton, Heather E Stefanski, Todd E DeFor, Ryan Shanley, Jaebok Choi, John F DiPersio, Mark Juckett, Jeffrey S Miller, Daniel J Weisdorf, Mark ...> ;Transplantation and Cellular Therapy. 2023 May 1
• 3 citations
  Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation.
  Nuttavut Sumransub, Qing Cao, Mark Juckett, Brian Betts, Shernan Holtan, Najla El Jurdi, Marie Hu, Jeremy Allred, Rita Assi, Joseph E Maakaron> ;Transplantation and Cellular Therapy. 2023 Apr 1
• Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study.
  Binod Dhakal, Mei-Jei Zhang, Linda J Burns, Xiaoying Tang, Christa Meyer, Lih-Wen Mau, Ajay K Nooka, Edward Stadtmauer, Ivana N Micallef, Joseph McGuirk, Luciano Costa...> ;Haematologica. 2023 Aug 1
• 1 citations
  A biobehavioral intervention to enhance recovery following hematopoietic cell transplantation: Protocol for a feasibility and acceptability randomized control trial.
  Andrew Kirvin-Quamme, Meredith E Rumble, Lisa Cadmus-Bertram, Mark B Juckett, Paul J Rathouz, Gwynneth Schell, Natalie S Callander, Peiman Hematti, Erin S Costanzo> ;Contemporary Clinical Trials Communications. 2022 Aug 1
• 16 citations
  Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis.
  Joseph E Maakaron, Mei-Jie Zhang, Karen Chen, Sunil Abhyankar, Vijaya Raj Bhatt, Saurabh Chhabra, Najla El Jurdi, Sherif S Farag, Fiona He, Mark Juckett, Marcos de Lim...> ;Bone Marrow Transplantation. 2022 Jun 1
• 8 citations
  Predictors of posttraumatic growth among hematopoietic cell transplant recipients.
  Jessica R Schwartz, Emily B K Thomas, Mark B Juckett, Erin S Costanzo> ;Psycho-Oncology. 2022 Jun 1
• 2 citations
  Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice.
  Betty K Hamilton, Corey Cutler, Clint Divine, Mark Juckett, Charles LeMaistre, Susan Stewart, Jennifer Wilder, Mary Horowitz, Nandita Khera, Linda J Burns> ;Transplantation and Cellular Therapy. 2022 Aug 1
• 5 citations
  Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes.
  Malika Kapadia, Leslie Lehmann, Jeffery Auletta, Lisa Beatty, Neel Bhatt, Robyn Blacken, Kathy Demmel, Therese Dodd, Catherine Desmond, Taylor Fitch, Laura Flesch, Dav...> ;Transplantation and Cellular Therapy. 2022 May 1
• 12 citations
  Sleep Disruption, Fatigue, and Depression as Predictors of 6-Year Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation
  Kelly E. Rentscher, Judith E. Carroll, Mark B. Juckett, Christopher L. Coe, Aimee Teo Broman, Paul J. Rathouz, Peiman Hematti, Erin S. Costanzo> ;Journal of the National Cancer Institute. 2021 Oct 1
• 1 citations
  Barriers and facilitators to the use of survivorship care plans by hematopoietic stem cell transplant survivors and clinicians.
  Colleen M. Morken, Amye J. Tevaarwerk, Mark B. Juckett, Amanda K. Swiecichowski, James E. Haine, Xiao Zhang, Zachary T. Williams, Kirsten Norslien, Bethaney Campbell, ...> ;Supportive Care in Cancer. 2021 Sep 5
• 3 citations
  Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challeng...
  Erica D. Warlick, Celalettin Ustun, Astrid Andreescu, Anthony F. Bonagura, Andrew M. Brunner, Abhinav B. Chandra, James M. Foran, Mark B. Juckett, Tamila L. Kindwall-K...> ;Cancer. 2021 Aug 10
• 2 citations
  A Phase I trial of talazoparib in patients with advanced hematologic malignancies.
  Ajay K. Gopal, Rakesh Popat, Ryan J. Mattison, Tobias Menne, Adrian Bloor, Terry J. Gaymes, Asim Khwaja, Mark B. Juckett, Ying Chen, Matthew J. Cotter, Ghulam J. Mufti> ;International Journal of Hematologic Oncology. 2021 Jul 30
• 2 citations
  Concurrent Central Diabetes Insipidus and Acute Myeloid Leukemia.
  Stephanie L. Pritzl, Daniel R. Matson, Mark B. Juckett, David J. Ciske> ;Case Reports in Hematology. 2021 Feb 16
• 11 citations
  Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia.
  Muhammad Umair Mushtaq, Alexandra M. Harrington, Sibgha Gull Chaudhary, Laura C. Michaelis, Karen Carlson, Sameem Abedin, Lyndsey Runass, Natalie S. Callander, Michael...> ;Leukemia & Lymphoma. 2021 Jan 2
• 106 citations
  Belumosudil for Chronic Graft-versus-Host Disease (cGVHD) After 2 or More Prior Lines of Therapy: The ROCKstar Study
  Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aleksandr Lazaryan, Aravind Ramakrishnan, Zachariah DeFilipp, Amandeep Salhotra, Wanxing Chai...> ;Blood. 2020 Nov 5
• 11 citations
  Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associat...
  Christopher D'Angelo, Aric C. Hall, Kaitlin M. Woo, Kyung Mann Kim, Walter L. Longo, Peiman Hematti, Natalie S. Callander, Vaishalee P. Kenkre, Ryan J. Mattison, Mark ...> ;Leukemia Research. 2020 Sep 1
• 51 citations
  Hematopoietic cell transplantation, Version 2.2020
  Ayman Saad, Marcos de Lima, Sarah Anand, Vijaya Raj Bhatt, Ryan Bookout, George Chen, Daniel R. Couriel, Antonio Di Stasi, Areej El-Jawahri, Sergio Giralt, Jonathan A....> ;Journal of the National Comprehensive Cancer Network. 2020 May 1
• 13 citations
  Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood ...
  Zachariah DeFilipp, Richard Gopez Ancheta, Ying Liu, Zhen-Huan Hu, Robert Peter Gale, David S. Snyder, Harry C. Schouten, Matt Kalaycio, Gerhard C. Hildebrandt, Celale...> ;Biology of Blood and Marrow Transplantation. 2020 Mar 1
• Join now to see all

Journal Articles

• What is the value of the computer to the physician?  
  MB Juckett, JS Spratt, Journal of Surgical Oncology 34:1-5
• Iron chelation impairs clonogenic survival and enhances gamma radiation induced injury of endothelial cells.  
  MB Juckett, A Zheng, J Shadley, Radiation Research 149: 330-337
• Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction.  
  CJ Link, RK Burt, AE Traynor, WR Drobyski, T Seregina, JP Levy, L Gordon, ST Rosen, WH Burns, B Camitta, J Casper, M Horowitz, M Juckett, C Lawton, D Margolis, D Pietr..., Human Gene Therapy 9(1):115-34
• Heme and endothelium: Effects of Nitric Oxide on Catalytic Iron, and Heme Degradation by Heme Oxygenase.  
  MB Juckett, Y Zheng, H Yuan, T Pastor, W Antholine, M Weber, GM Vercellotti, Journal of Biological Chemistry 273(36):23388-23397
• Captopril to Mitigate Chronic Renal Failure After Hematopoietic Stem Cell Transplantation: A Randomized Controlled Trial.  
  Cohen EP, Irving AA, Drobyski WR, Klein JP, Passweg J, Talano JA, Juckett MB, Moulder JE, Int J Radiat Oncol Biol Phys
• Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging.  
  Vanderhoek M, Juckett MB, Perlman SB, Nickles RJ, Jeraj R, Leuk Res
• Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS).  
  Cashen A, Juckett M, Jumonville A, Litzow M, Flynn PJ, Eckardt J, Laplant B, Laumann K, Erlichman C, Dipersio J, Ann Hematol
• American Society of Blood and Marrow Transplantation Guidelines for Training in Hematopoietic Progenitor Cell Transplantation.  
  Khan S, Juckett MB, Komanduri KV, Krishnan A, Burns LJ, Biol Blood Marrow Transplant
• Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refrac...  
  Erba HP, Sayar H, Juckett M, Lahn M, Andre V, Callies S. Schmidt S, Kadam S, Brandt JT, Van Bockstaele D, Andreeff M, Invest New Drugs
• The Match is Back.  
  Juckett MB, The Hematologist
• Learning in Las Vegas: The ASH State-of-the-Art Symposium.  
  Juckett MB, The Hematologist
• Join now to see all

Abstracts/Posters

• S-nitroso-penicillamine modulates the induction of ferritin by iron in endothelial cells.
  MB Juckett, J Balla, ML Weber, JM Peloquin, HS Jacob, GM Vercellotti, Clin Res 41(3):668A
• Ferritin protects endothelial cells from oxidized low-density lipoprotein mediated cytotoxicity.
  MB Juckett, J Balla, G Balla, B Burke, HS Jacob, GM Vercellotti, Clin Res 41(2):162A
• Endothelial ferritin induction by iron is inhibited by nitric oxide generators.
  MB Juckett, J Balla, ML Weber, JM Peloquin, HS Jacob, GM Vercellotti, Blood 82(10, Suppl 1): 1993
• Nitric oxide as an antioxidant: role in LDL oxidation, endothelial cell injury, and iron availability.
  MB Juckett, J Murar, ML Weber, HS Jacob, GM Vercellotti, Clin Res 42(3):360A
• Endothelial cell lysis and programmed cell death: cytoprotective role of ferritin.
  A Kovacs, MB Juckett, HS Jacob, GM Vercellotti, Clin Res 42(3):376A
• Endothelial cell lysis and programmed cell death: cytoprotective role of ferritin.
  Kovacs, MB Juckett, HS Jacob, GM Vercellotti, Clin Res 42(3):376A
• Nitric oxide blocks ferritin induction by iron and protects endothelial cells from iron mediated oxidative injury.
  MB Juckett, J Balla, ML Weber, HS Jacob, GM Vercellotti, Clin Res 42(2):182A
• Endothelial cells heme oxygenase and ferritin induction in rat lungs by hemoglobin in vivo.
  J Balla, G Balla, KA Nath, MB Juckett, HS Jacob, GM Vercellotti, Clin Res 42(2):146A
• T-cell depleted allogeneic bone marrow transplant for non-Hodgkin's lymphoma: A single institution experience in 32 patients.
  MB Juckett, P Rowlings, W Drobyski, M Horowitz, C Lawton, C Keever, D Pietryga, J Casper, B Camitta, D Margolis, G Hanson, Blood 86(10 Suppl 1):210a
• Iron deprivation reduces clonogenic survival, induces apoptosis and enhances radiation toxicity in endothelial cells.
  MB Juckett, J Shadley, Y Zhen, Blood 86(10 Suppl 1):976a
• Benefit of angiotensin antagonism in bone marrow transplant nephropathy.
  E Cohen, MB Juckett, J Am Soc Nephrol 7:1370
• Nitric oxide inhibits the catabolism of cellular heme.
  M Juckett, Y Zheng, H Yuan, T Pastor, W Antholine, Proc. Annual Meeting of the Oxygen Society
• Effect of T-cell subset dose on outcome of T-cell depleted bone marrow transplantation.
  Y Kawanishi, J Passweg, WR Drobyski, A Cook-Craig, J Casper, D Pietryga, F Garbrecht, B Camitta, M Horowitz, M Juckett, D Margolis, P Rowlings, N Flomenberg, CA Keever..., Biol Blood Marrow Transplant 2:150
• Bone marrow transplantation (BMT) using genotypically haploidentical donors.
  D Pietryga, J Casper, D Margolis, B Camitta, F Garbrecht, W Drobyski, M Horowitz, W Burns, M Juckett, P Rowlings, J Passweg, C Lawton, C Taylor, L Baxter-Lowe, K Murra..., Blood 88 (10 Suppl 1):264a
• Unrelated donor marrow transplantation for acute myelogenous leukemia (AML), myelodysplasia, and secondary MAL.
  WR Drobyski, M Horowitz, D Pietryga, D Margolis, M Juckett, W Burns, B Camitta, P Rowlings, C Keever-Taylor, J Casper, Blood 88 (10 Suppl 1):269a
• Heme and endothelium: Effects of nitric oxide on catalytic iron, ferritin, and heme oxygenase activity.
  MB Juckett, Y Zheng, H Yuan, T Pastor, W Antholine, M Weber, and GM Vercellotti, J of Investigative Medicine 45 (3):1997
• Desferrioxamine treatment of endothelial cells lowers clonogenic survival and increases the clastogenic effects of gamma-radiation.
  MB Juckett, JD Shadley, Y Zheng, Blood 90 (10 Suppl 1): 77b
• Heme and endothelium: effects of nitric oxide on catalytic iron and heme degradation by heme oxygenase.
  MB Juckett, Y Zheng, H Yuan, T Pastor, W Antholine, M Weber, GM Vercellotti, Blood 90 (10 Suppl 1): 77b
• Genetic markers associated with thrombosis in patients with thrombotic thrombocytopenic purpura.
  T Raife, B Atkinson, M Hessner, M Juckett, J Gottschall, Blood 90 (10 Suppl 1): 88b
• A unique case of chronic myelogenous leukemia-related thrombotic thrombocytopenic purpura resolving with bone marrow transplantation.
  JD Burfeind, MB Juckett, JL Gottschall, Blood 90 (Suppl 1): 395b
• Epstein Barr virus CTL precursor (CTLp) frequency and HLA restriction patterns in ex vivo generated EBV-specific T cell lines.
  CA Keever-Taylor, RJ Orentas, B Davies, M Juckett, D Margolis, Tandem BMT Meetings, Keystone, CO
• A Comparitic Analysis of Transplant Outcomes in Patients receiving Unrelated versus Highly HLA-disparate Haploidentical Family Member Donor Marrow Grafts for the treat...
  W. R. Drobyski, J. Klein, D. Pietryga, N. Flomenberg, C. Kabler-Babbitt, D. H. Vesole, D. A. Margolis, C. A. Keever-Taylor, M. Horowitz, M. Juckett, J. D. Rizzo, D. Ba..., Blood 94 (Suppl 1): 564a
• Generation of Epstein Barr Virus-Specific T cell lines from Patient Blood Post Bone Marrow and Solid Organ Transplantation.
  CA Keever-Taylor, RJ Orentas, M Juckett, J Casper, D Margolis, B Davies, S Konings, P Rivers, and W Burns, International Society for Hematotherapy and Graft Engineering Meeting., San Diego, CA
• Anti-CD20 Monoclonal antibody treatment for post-transplant B-cell lymphoma.
  N Siddiqi, M Juckett, R Orentas, B Bresnahan, S Hariharan, Joint Meeting of the American Society of Transplant Surgeons and the American Society of ...., Chicago, IL
• Loss of Renal Function following Bone Marrow Transplantation: An analysis of Angiotensin Converting Enzyme D/I Polymorphism and other Clinical Risk Factors.
  MB Juckett, EP Cohen, CA Keever-Taylor, Y Zheng, CA Lawton, JE Moulder, J Klein, Blood 96 (Suppl 1): 394a
• Join now to see all

Lectures

• Adult and Pediatric BMT 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• A Phase II Study of Decitabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Patients with Myeloid Malignancies 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Introduction to Practice-Improvement Modules. 
  American Society of Blood and Marrow Transplantation
• How to Negotiate ASH. 
  Trainee Reception, American Society of Hematology Annual Meeting
• Monoclonal Antibodies of Potential Use in Stem Cell Transplantation. 
  Tandem Bone Marrow Transplantation Meeting, Keystone CO
• Heme and the Endothelium: Effect of Nitric Oxide on Catalytic iron and Ferritin. 
  Gordon Research Conference: Oxygen Radicals, Ventura CA
• Join now to see all